| Name | Title | Contact Details |
|---|
Respitech Medical Inc is a Lancaster, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
pSivida is a leading provider of miniaturized, sustained-release drug delivery products and is continuing the evolution of these systems.
Health Management Associates is a for-profit corporation which operates hospitals and other health care facilities in the southern United States. It is headquartered at 5811 Pelican Bay Blvd. in North Naples, Florida. Its current CEO is Gary D. Newsome. Serving on the board of directors are William Schoen, Pascal Goldschmidt, Donald Kiernan, William Steere, Vicki O'Meara, Robert Knox, Kent Dauten and Randolph W. Westerfield. Health Management Associates (HMA) is an organization that provides people, processes, capital, and subject matter expertise to hospitals and physician practices per their individual needs or governing requirements (1). Additional functions that HMA provides to hospitals and provider groups are to invest capital for renewal of hospital facilities, recruiting of physicians to expand community resources or hospital services, and promote the use standardized best practices throughout HMA facilities.
Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.
Urologist Dallas Texas Medical City Hospital Robotic and Laparoscopic Surgery Prostate and Kidney UANT Urology Associates of North Texas Richard Bevan-Thomas MD enlarged prostate treatment vasectomy incontinence Dallas Plano Mesquite Garland Richardson